Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 33, 2016 - Issue 1
Submit an article Journal homepage
333
Views
5
CrossRef citations to date
0
Altmetric
Retinoblastoma

Favorable outcome of alternate systemic and intra-arterial chemotherapy for retinoblastoma

Seung Min HahnDivision of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Korea;Department of Pediatric Hemato-Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, Korea
,
Hyo Sun KimDivision of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Korea;Department of Pediatric Hemato-Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, Korea
,
Dong Joon KimDepartment of Radiology, Yonsei University College of Medicine, Seoul, Korea
,
Sung Chul LeeDepartment of Ophthalmology, The Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea
,
Chuhl Joo LyuDivision of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Korea;Department of Pediatric Hemato-Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, Korea
&
Jung Woo HanDivision of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Korea;Department of Pediatric Hemato-Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, KoreaCorrespondence[email protected]
Pages 74-82 | Received 26 Oct 2015, Accepted 19 Dec 2015, Published online: 22 Feb 2016

References

  • Zanaty M, Barros G, Chalouhi N, et al. Update on Intra-arterial chemotherapy for retinoblastoma. Sci World J. 2014;2014:869604.
  • Rodriguez-Galindo C, Wilson MW, Chantada G, et al. Retinoblastoma: one world, one vision. Pediatrics. 2008;122:e763–e770.
  • Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 2010;21:203–212.
  • Park SJ, Woo SJ, Park KH. Incidence of retinoblastoma and survival rate of retinoblastoma patients in Korea using the Korean National Cancer Registry database (1993–2010). Invest Ophthalmol Vis Sci. 2014;55:2816–2821.
  • Reese AB, Hyman GA, Tapley ND, et al. The treatment of retinoblastoma by x-ray and triethylene melamine. AMA Arch Ophthalmol. 1958;60:897–906.
  • Kiribuchi M. [Retrograde infusion of anti-cancer drugs to ophthalmic artery for intraocular malignant tumors]. Nihon Ganka Gakkai Zasshi. 1966;70:1829–1833.
  • Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004;9:69–73.
  • Suzuki S, Kaneko A. Management of intraocular retinoblastoma and ocular prognosis. Int J Clin Oncol. 2004;9:1–6.
  • Gobin YP, Dunkel IJ, Marr BP, et al. Intra-arterial chemotherapy for the management of retinoblastoma: four-comment experience. Arch Ophthalmol. 2011;129:732–737.
  • Shields CL, Manjandavida FP, Lally SE, et al. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma. Ophthalmology. 2014;121:1453–1460.
  • Gobin P, Abramson D. Abstract No. 60: A phase I/II study of intra-arterial (ophthalmic artery) chemotherapy for intraocular retinoblastoma. J Vasc Interv Radiol. 2008;19(2, Suppl):S24–S25.
  • Chantada GL, Guitter MR, Fandino AC, et al. Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve. Pediatr Blood Cancer. 2009;52:218–222.
  • Aerts I, Sastre-Garau X, Savignoni A, et al. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation. J Clin Oncol. 2013;31:1458–1463.
  • Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report no. 2, treatment complications. Arch Ophthalmol. 2011;129:1407–1415.
  • Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol. 2002;120:923–931.
  • Choi S, Han JW, Kim H, et al. Combined chemotherapy and intra-arterial chemotherapy of retinoblastoma. Korean J Pediatr. 2013;56:254–259.
  • Eagle RC Jr. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med. 2009;133:1203–1209.
  • Cuenca A, Giron F, Castro D, et al. Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome. Arch Ophthalmol. 2009;127:1006–1010.
  • Kaliki S, Shields CL, Rojanaporn D, et al. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes. Ophthalmology. 2013;120:997–1003.
  • Abramson DH, Marr BP, Brodie SE, et al. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five comment review. PLoS ONE. 2012;7:e34120.
  • Shields CL, Kaliki S, Al-Dahmash S, et al. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation. Retina. 2013;33:2103–2109.
  • Marr BP, Brodie SE, Dunkel IJ, et al. Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results. Br J Ophthalmol. 2012;96:1300–1303.
  • Abramson DH, Dunkel IJ, Brodie SE, et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115:1398–1404, 1404 e1391.
  • Phillips TJ, McGuirk SP, Chahal HK, et al. Autonomic cardio-respiratory reflex reactions and superselective ophthalmic arterial chemotherapy for retinoblastoma. Paediatr Anaesth. 2013;23:940–945.
  • Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113:2276–2280.
  • Kim JH, Yu YS, Khwarg SI, et al. Clinical result of prolonged primary chemotherapy in retinoblastoma patients. Korean J Ophthalmol. 2003;17:35–43.
  • Kim H, Lee JW, Kang HJ, et al. Clinical results of chemotherapy based treatment in retinoblastoma patients: a single center experience. Cancer Res Treat. 2008;40:164–171.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.